$99.99
GH secretagogue research blend. CJC-1295 10mg + Ipamorelin 10mg = 20mg total. Most studied GHRH + GHRP combination. ≥99% purity — Vanguard verified. Batch-specific COA. For research use only — not for human consumption.
This compound is in our testing pipeline and not yet available for purchase. Join the Be First waitlist for launch pricing and first access the moment it goes live.
Notify Me When This LaunchesDescription
CJC-1295 + Ipamorelin Blend — GH Secretagogue Research Stack
The CJC-1295 + Ipamorelin combination is the most studied dual GH secretagogue protocol in preclinical research. CJC-1295 acts as a GHRH receptor agonist while Ipamorelin acts as a selective ghrelin receptor agonist — two complementary mechanisms for studying GH pulse dynamics. This combination represents approximately 10% of all research peptide demand and is the most purchased GH-related research blend.
Blend Composition
- CJC-1295 (No DAC) — 10mg (CAS: 446262-90-4)
- Ipamorelin — 10mg (CAS: 170851-70-4)
- Total: 20mg per vial
Specifications
- Form: Lyophilized Powder — all components
- Purity: ≥99% on all components — Vanguard Laboratory Verified
- Storage: -20°C Lyophilized / 4°C Reconstituted
- Volume: 3ml
Testing and Verification
Every batch independently tested by Vanguard Laboratory — ISO/IEC 17025:2017 accredited, A2LA Certificate #6377.01.
For Research Use Only — Not For Human Consumption.
Additional information
| Weight | 0.1 lbs |
|---|
Reviews
There are no reviews yet.